Valeant Files Another Complaint Over 'False' Allergan Info
Valeant Pharmaceuticals International Inc. on Thursday filed another complaint, this time with a Canadian regulator, accusing $53 billion takeover target Allergan Inc. of making "false and misleading" statements about Valeant's business...To view the full article, register now.
Already a subscriber? Click here to view full article